In preclinical models of α‐Synucleinopathies, USP13 assumes a dual regulatory role, independently influencing the ubiquitination of both Parkin and α‐Synuclein, critical players in PD pathogenesis [127] (Figure 3A,C). Here, PRKN is linked to Parkinson disease.